Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

REGISTER for free or LOG IN to view this content

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Lipids

Coronary

CAD Pharma

OCT

IVUS/NIRS

Presentation

ACC 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.